Amgen Inc. (AMGN) Social Stream
AMGEN INC (AMGN) Price Targets From Analysts
Use the tables below to see what analysts covering AMGEN INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 18 | $298 | $185 | $242.866 | $245.17 | -0.94% |
| 2021-11-19 | 19 | $298 | $185 | $241.937 | $245.17 | -1.32% |
| 2021-11-22 | 20 | $298 | $185 | $239.117 | $245.17 | -2.47% |
| 2021-12-20 | 21 | $298 | $185 | $237.5 | $245.17 | -3.13% |
| 2021-12-22 | 20 | $298 | $185 | $237.888 | $245.17 | -2.97% |
| 2022-01-04 | 19 | $298 | $185 | $237.888 | $245.17 | -2.97% |
| 2022-01-07 | 19 | $298 | $185 | $235.611 | $245.17 | -3.9% |
| 2022-01-18 | 18 | $298 | $185 | $236.764 | $245.17 | -3.43% |
| 2022-01-28 | 18 | $298 | $185 | $236.647 | $245.17 | -3.48% |
| 2022-02-08 | 18 | $298 | $194 | $239.875 | $245.17 | -2.16% |
| 2022-03-18 | 18 | $298 | $194 | $246.125 | $245.17 | 0.39% |
| 2022-04-12 | 17 | $286 | $194 | $242.8 | $245.17 | -0.97% |
| 2022-04-26 | 17 | $295 | $194 | $243.8 | $245.17 | -0.56% |
| 2022-04-29 | 15 | $295 | $194 | $247.571 | $245.17 | 0.98% |
| 2022-05-10 | 15 | $295 | $208 | $248.785 | $245.17 | 1.47% |
| 2022-05-23 | 16 | $295 | $208 | $249.266 | $245.17 | 1.67% |
| 2022-05-31 | 16 | $295 | $208 | $249.6 | $245.17 | 1.81% |
| 2022-06-15 | 16 | $295 | $208 | $249.933 | $245.17 | 1.94% |
| 2022-07-25 | 16 | $295 | $208 | $252.571 | $245.17 | 3.02% |
| 2022-08-03 | 16 | $295 | $208 | $250.866 | $245.17 | 2.32% |
| 2022-08-05 | 17 | $295 | $208 | $250.866 | $245.17 | 2.32% |
| 2022-08-08 | 17 | $295 | $208 | $252.666 | $245.17 | 3.06% |
| 2022-09-17 | 18 | $295 | $182 | $248.25 | $245.17 | 1.26% |
| 2022-10-03 | 18 | $295 | $182 | $250.133 | $245.17 | 2.02% |
| 2022-10-11 | 18 | $295 | $182 | $251.6 | $245.17 | 2.62% |
| 2022-10-21 | 18 | $295 | $182 | $251.466 | $245.17 | 2.57% |
| 2022-10-24 | 18 | $295 | $182 | $254 | $245.17 | 3.6% |
| 2022-11-02 | 18 | $295 | $182 | $254 | $245.17 | 3.6% |
| 2022-11-03 | 17 | $295 | $182 | $254 | $245.17 | 3.6% |
| 2022-11-04 | 17 | $300 | $182 | $256.666 | $245.17 | 4.69% |
| 2022-11-08 | 18 | $300 | $182 | $257.6 | $245.17 | 5.07% |
| 2022-12-04 | 13 | $325 | $182 | $259.461 | $245.17 | 5.83% |
| 2022-12-07 | 13 | $325 | $182 | $260.23 | $245.17 | 6.14% |
| 2022-12-12 | 12 | $325 | $182 | $261.692 | $245.17 | 6.74% |
| 2022-12-14 | 12 | $325 | $182 | $262 | $245.17 | 6.86% |
| 2022-12-22 | 12 | $325 | $182 | $264 | $245.17 | 7.68% |
| 2023-01-19 | 13 | $325 | $182 | $266.23 | $245.17 | 8.59% |
| 2023-01-27 | 13 | $325 | $182 | $266.692 | $245.17 | 8.78% |
| 2023-02-01 | 14 | $325 | $182 | $267.461 | $245.17 | 9.09% |
| 2023-02-02 | 14 | $325 | $182 | $263.384 | $245.17 | 7.43% |
The Trend in the Analyst Price Target
AMGN's average price target has moved up $15.13 over the prior 170 days.
AMGN reports an average of -2.06% for its upside potential over the past 51 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-04-26 | 17 | 295 | 194 | 243.800 | 249.87 | -2.43% |
| 2022-06-01 | 16 | 295 | 208 | 249.933 | 253.42 | -1.38% |
| 2022-08-03 | 16 | 295 | 208 | 250.866 | 247.14 | 1.51% |
| 2022-11-03 | 17 | 295 | 182 | 254.000 | 265.88 | -4.47% |
| 2022-11-08 | 17 | 325 | 182 | 259.461 | 292.39 | -11.26% |
AMGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.71 | 4 | 0 | 8 | 2 | 2 | 14 |
The Trend in the Broker Recommendations
AMGN's average broker recommendation rating worsened by 0.15 over the prior 13 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, AMGEN INC's average analyst price target is greater than 4617.07% of them.
- AMGEN INC's number of analysts covering the stock is higher than 4642.56% of Pharmaceutical Products stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AMGEN INC's upside potential (average analyst target price relative to current price) is higher than 479.4% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, AMGEN INC's variance in analysts' estimates is lower than -1488.67% of them.
Stocks similar to AMGEN INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are DNA, CGC, and TLRY.
View All Top Stocks by Price Target
Is AMGN a Buy, Hold or Sell? See the POWR Ratings now!